In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...